tetano
Editor, Senior Moderator
Vaccine. 2017 Jan 21. pii: S0264-410X(17)30041-5. doi: 10.1016/j.vaccine.2017.01.022. [Epub ahead of print]
[h=1]The Advisory Committee on Immunization Practices' controversial recommendation against the use of live attenuated influenza vaccine is based on a biased study design that ignores secondary protection.[/h] Small PA Jr[SUP]1[/SUP], Cronin BJ[SUP]2[/SUP].
[h=3]Author information[/h]
[h=4]KEYWORDS:[/h] ACIP; Influenza; SLIV; Test negative case control; Vaccine
PMID: 28118937 DOI: 10.1016/j.vaccine.2017.01.022
[PubMed - as supplied by publisher]
[h=1]The Advisory Committee on Immunization Practices' controversial recommendation against the use of live attenuated influenza vaccine is based on a biased study design that ignores secondary protection.[/h] Small PA Jr[SUP]1[/SUP], Cronin BJ[SUP]2[/SUP].
[h=3]Author information[/h]
[h=4]KEYWORDS:[/h] ACIP; Influenza; SLIV; Test negative case control; Vaccine
PMID: 28118937 DOI: 10.1016/j.vaccine.2017.01.022
[PubMed - as supplied by publisher]